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Background: Considering that vitamin A deficiency modulates hepcidin expression and consequently affects iron
metabolism, we evaluated the effect of vitamin A deficiency in the expression of genes involved in the hemojuvelin
(HJV)-bone morphogenetic protein 6 (BMP6)-small mothers against decapentaplegic protein (SMAD) signaling pathway.
Methods: Male Wistar rats were treated: control AIN-93G diet (CT), vitamin A-deficient diet (VAD), iron-deficient diet
(FeD), vitamin A- and iron-deficient diet (VAFeD), or 12 mg all-trans retinoic acid (atRA)/kg diet.
Results: Vitamin A deficiency (VAD) increased hepatic Bmp6 and Hfe2 mRNA levels and down-regulated hepatic Hamp,
Smad7, Rarα, and intestinal Fpn1 mRNA levels compared with the control. The FeD rats showed lower hepatic Hamp,
Bmp6, and Smad7 mRNA levels compared with those of the control, while in the VAFeD rats only Hamp and Smad7
mRNA levels were lower than those of the control. The VAFeD diet up-regulated intestinal Dmt1 mRNA levels in relation
to those of the control. The replacement of retinyl ester by atRA did not restore hepatic Hamp mRNA levels; however,
the hepatic Hfe2, Bmp6, and Smad7 mRNA levels were similar to the control. The atRA rats showed an increase of hepatic
Rarα mRNA levels and a reduction of intestinal Dmt1 mRNA and Fpn1 levels compared with those of the control.
Conclusions: The HJV-BMP6-SMAD signaling pathway that normally activates the expression of hepcidin in iron
deficiency is impaired by vitamin A deficiency despite increased expression of liver Bmp6 and Hfe2 mRNA levels
and decreased expression of Smad7 mRNA. This response may be associated to the systemic iron deficiency and
spleen iron retention promoted by vitamin A deficiency.
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Iron deficiency affects approximately 20 % of the world
population and is the most prevalent nutritional deficiency
worldwide (Martínez-Navarrete et al. 2002; Brasil 2007;
Assunção et al. 2007). The condition is often considered* Correspondence: jufrossard@gmail.com
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et al. 2006).
Hepcidin, a peptide hormone secreted by the liver, is an
essential molecule for systemic iron homeostasis regulation.
The primary role of hepcidin is to control the amount of
iron that is released into the circulation from enterocytes
and spleen macrophages. Hepcidin binds to ferroportin,
which is an iron exporter protein found in most body cell
membranes, and triggers the internalization of ferroportin,
ubiquitination, and subsequent lysosomal degradation. The
result is the prevention of the iron release from enterocytes
and splenic macrophages. Hepcidin gene expression ise is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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inflammation, erythropoiesis, and hypoxia (Evstatiev and
Gasche 2012).
When body iron stores are high, hepcidin expression is
increased, which consequently inhibits iron mobilization
from tissues and iron absorption from the diet (Anderson
et al. 2009; Hentze et al. 2010). The pathway that modu-
lates hepcidin expression in response to intracellular iron
status appears to be dependent on the hemojuvelin (HJV)
protein and bone morphogenetic protein 6 (BMP6). The
binding of the BMP6 to the BMP receptor (BMPR) and its
essential co-receptor HJV leads to the phosphorylation of
small mothers against decapentaplegic protein (SMAD) 1,
5, and 8. Phosphorylated SMAD 1/5/8 forms a complex
with SMAD 4 that is translocated to the nucleus before
activating the hepcidin promoter; this process induces
iron retention in tissues (Hentze et al. 2010; Lee et al.
2010; Zhang et al. 2010; Zhang 2010). The BMP6 pathway
also induces negative regulators of hepcidin, such as
SMAD 7, so that a negative feedback loop that controls
hepcidin expression is established. This mechanism pre-
vents excessive hepcidin production, which in turn could
lead to iron deficiency (Evstatiev and Gasche 2012).
Recent studies suggest that the metabolism of vitamin
A and iron is interrelated (Citelli et al. 2012; Jiang et al.
2012; Tsuchiya et al. 2009). In vitamin A-deficient or-
ganisms, systemic iron availability appears to be signifi-
cantly reduced and iron is accumulated in tissues,
especially in the spleen (Tsuchiya et al. 2009; Arruda
et al. 2009). Although preliminary data clearly show that
vitamin A affects iron homeostasis (Arruda et al. 2009),
the mechanism by which retinoids modulate systemic iron
homeostasis is unclear. Several physiological processes,
such as cell proliferation and differentiation, are modu-
lated by retinoids. The all-trans retinoic acid (atRA),
which is the most active form of retinoids, modulates the
expression of several genes at the transcriptional level by
binding to nuclear receptors, the retinoic acid receptor
(RAR), and the retinoid X receptor (RXR), which are
transcription factors (Ziouzenkova and Plutzky 2008;
Theodosiou et al. 2010).
To explore how vitamin A deficiency alters iron me-
tabolism, the present study evaluated the expression of
genes involved in the HJV-BMP6-SMAD signaling path-
way. The study also considered the possible involvement
of retinoic acid and retinoid X nuclear receptors in the




Thirty 21-day-old male Wistar rats (65.7 ± 5.5 g) were
housed individually in stainless steel cages and were
maintained under a 12 h light cycle at 22 ± 2 °C with freeaccess to water, and food access was allowed only during
the dark cycle. The present study was approved by the
Animal Care and Use Committee of the University of
Brasília (UnBDoc 52606/2011). All applicable national
and institutional guidelines for the care and use of
animals were followed.
After 7 days of acclimatization, rats were randomly
assigned to five groups (six rats per group). The control
group (CT) was fed with an AIN-93G diet (Reeves et al.
1993), containing 4000 UI vitamin A/kg; the vitamin A-
deficient group (VAD) was fed with an AIN-93G diet
without a source of vitamin A; the vitamin A- and iron-
deficient group (VAFeD) was fed with an AIN-93G diet
without sources of vitamin A and iron; the iron-deficient
group (FeD) was fed with an AIN-93G diet without a
source of iron; and the retinoic acid group (atRA) was
fed with an AIN-93G diet containing 12 mg of atRA/kg
as the only source of vitamin A. The animals were
weighed weekly, and food intake was recorded daily.
After 59 days of feeding the experimental diets, the ani-
mals were denied food for 14 h and sacrificed after being
anesthetized with 3 % isoflurane. Blood was collected by
cardiac puncture into tubes containing 7.0 % ethylene-
diaminetetraacetic acid (21 μL/mL of blood). The liver,
spleen, and small intestine (a 1-cm length of small intes-
tine distal to the pylorus and a 1-cm length proximal to
the ileocecal valve were excised, and the lumen was rinsed
with saline) were excised and washed in cold 0.9 % NaCl.
The samples were frozen in liquid nitrogen (N2) and
stored at −80 °C.
RNA extraction and reverse transcription-polymerase
chain reaction analysis (qRT-PCR)
The extraction of total RNA, purity and integrity of the
RNA samples, and the cDNA synthesis were performed
as described previously (Cunha et al. 2014).
Quantitative real-time PCR was performed using the
Fast SYBR Green Master Mix 2x reagent (Applied Biosys-
tems, Foster City, CA, USA) with 2.0 μL of cDNA diluted
50 times (corresponding to 2 ng of total RNA). The final
volumes were 10 and 5 μL Fast SYBR Green Master Mix
and 10 μmol/L (final concentration) of each primer. The
following primers were used for each target genomic re-
gion: for hepcidin, Hamp TGATGCTGAAGCGAAGGA
(forward) and TGTGTTGAGAGGTCAGGAC (reverse);
for hemochromatosis type 2 (juvenile) homolog, Hfe2
GTAGCATCGGGAGCCAAC (forward) and TCAAAGG
CTGCAGGAAGATT (reverse); for bone morphogenetic
protein 6, Bmp6 GACAGCAGAGTCGCAATCG (forward)
and AGCTCACGTAAAGCTCATGC (reverse); for SMAD
family member 7, Smad7 AGAGGCTGTGTTGCTGTG
(forward) and CATCGGGTATCTGGAGTAAGG (reverse);
for retinoic acid receptor alpha, Rarα ACCATTGCCGAC
CAGATTACCC (forward) and AAGGTCATTGTGTCTT
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CTTCCCAGTCATCAGTTCTTCC (forward) and GGTG
GCTTCACATCTTCAGG (reverse); for divalent metal
transporter 1, Dmt1 or solute carrier family 11 member 2,
Scl11a2 CTGATTTACAGTCTGGAGCAG (forward) and
CACTTCAGCAAGGTGCAA (reverse); for ferroportin 1,
Fpn1 or solute carrier family 40 member 1, Slc40a1
TTCCGCACTTTTCGAGATGG (forward) and TACAGT
CGAAGCCCAGGACTGT (reverse); and for β-actin, Actb
GTCGTACCACTGGCATTGTG (forward) and CTCTCA
GCTGTGGTGGTGAA (reverse). Quantitative PCR was
performed using a 7500 Fast Real-Time PCR System
(Applied Biosystems, Cingapura) with 40 cycles at 95 °C
for 20 s, 60 °C for 3 s, and 60 °C for 20 s. “The expression
of all genes was normalized to the expression of the
housekeeping gene β-actin, and the reactions were run in
triplicate. The amplification efficiency was determined
from the slope obtained from the standard curve relating
log [transcribed mRNA] and variation threshold cycle
(CT) with the equation E = (10 − 1/slope − 1) × 100, and a
slope value of the regression line plot of CT values versus
log of input nucleic acid of approximately −3.32 was con-
sidered an efficient reaction. PCR efficiency was between
102 and 109 % for all primers. A standard curve was plot-
ted for each gene, which correlated the ΔCT (CT target −
CT reference) versus the log of the cDNA amount, and a
slope value of the regression line plot of ΔCT values versus
log of input nucleic acid of less than 0.1 was used as a gen-
eral criterion to accept the validation of the experiment.
Based on the data obtained previously, a 1:50 dilution of
cDNA was used to analyze qRT-PCR, where the efficiency
was higher than 99 %. Melting curve analysis was used to
examine the specificity of the products generated for each
primer set. The comparative CT method was used to
quantitate the abundance of the target gene mRNA and is
given by 2−ΔΔCT .” This method was performed as de-
scribed in the tutorial, “Guide to Performing Relative
Quantitation of Gene Expression Using Real-Time Quan-
titative PCR” (Part #: 4371095 Rev B, Applied Biosystems).
Statistical analysis
Statistical analyses were performed using SPSS software
(version 19.0, SPSS Inc., Chicago, IL, USA). The normality
of data distribution was tested by the Kolmogorov-
Smirnov test. Differences between treatment groups were
tested by independent sample t test. In all tests, a value of
p < 0.05 was considered statistically significant.
Results
The effect of vitamin A deficiency and atRA on the
expression of mRNAs encoding proteins involved in iron
homeostasis: Hamp, Hfe2, Bmp6, and Smad7
Figure 1 shows the relative transcript levels of hepcidin
(Hamp), hemochromatosis type 2 (juvenile) homolog(Hfe2), bone morphogenetic protein 6 (Bmp6), and
SMAD family member 7 (Smad7) in rat livers, normal-
ized to β-actin (Actb) values. Compared to the control
group, vitamin A deficiency down-regulated Hamp (2.3-
fold, p < 0.001) and Smad7 (1.6-fold, p = 0.027) mRNA
levels in the liver and up-regulated hepatic Hfe2 (1.2-
fold, p = 0.026) and Bmp6 mRNA levels (2.0-fold, p =
0.0013). The consumption of atRA, as the only source of
dietary vitamin A, resulted in mRNA levels of Hfe2,
Bmp6, and Smad7 be similar to those values obtained in
the control group; however, the atRA diet failed to
reverse the inhibitory effect of vitamin A deficiency on
Hamp mRNA levels (2.8-fold, p = 0.002) in the liver. The
iron-deficient diet (FeD) down-regulated hepatic levels
of Hamp (58.7-fold), Bmp6 (1.6-fold), and Smad7 mRNA
(2.8-fold, p = 0.000, 0.002, and 0.005, respectively) com-
pared to those of the control group, and no difference
was observed in relation to hepatic Hfe2 mRNA levels.
The VAFeD group showed lower hepatic levels of Hamp
and Smad7 mRNA (12.6-fold and 2.4-fold, p = 0.000 and
0.006, respectively) relative to the control group, but no
difference was observed in the Hfe2 and Bmp6 mRNA
levels, between these two groups. The VAFeD diet also
significantly reduced the hepatic Hamp, Hfe2, Bmp6,
and Smad7 mRNA levels compared to those of the VAD
group (p < 0.001, 0.035, 0.0003, and 0.002, respectively;
Fig. 1), whereas only Bmp6 mRNA levels were signifi-
cantly increased in the VAFeD group compared to those
in the FeD group (p = 0.024).
The effect of vitamin A deficiency and atRA administration
on the Fpn1 and Dmt1 intestinal mRNA levels
Vitamin A deficiency promoted a decrease in Fpn1 mRNA
levels compared to the control group (1.6-fold, p = 0.043;
Fig. 2). This response was not reversed when retinyl ester
was replaced by all-trans retinoic acid in the diet; instead,
the atRA group also showed down-regulation of Fpn1
mRNA levels in the intestine relative to the control group
(p = 0.020). The VAFeD group showed higher Dmt1
mRNA levels than the control group (p = 0.001) and the
FeD group (p = 0.002). No difference was observed on the
Dmt1 mRNA levels in vitamin A- or iron-deficient rats
(VAD and FeD groups); however, the association of both
deficiencies (VAFeD group) up-regulated Dmt1 mRNA
levels relative to the control (1.8-fold, p = 0.001), VAD (1.8-
fold, p = 0.002), and FeD groups (1.5-fold, p = 0.002). The
administration of all-trans retinoic acid (atRA) promoted
the down-regulation of intestinal Dmt1 mRNA levels com-
pared to the control group (1.9-fold, p = 0.014; Fig. 2).
The effect of vitamin A deficiency and atRA on the Rarα
and Rxrβ mRNA levels in the liver
Vitamin A deficiency reduced the levels of hepatic
Rarα mRNA (1.2-fold, p = 0.001), while the atRA diet
Fig. 1 Relative transcript levels of hepcidin (Hamp) (a), hemochromatosis type 2 (juvenile) homolog (Hfe2) (b), bone morphogenetic protein 6
(Bmp6) (c), and SMAD family member 7 (Smad7) (d) in the livers normalized to β-actin (Actb) values of rats treated with diets containing different
sources and amounts of vitamin A and iron for 59 days. Mean ± standard deviation, *p < 0.05 versus the CT group, †p < 0.05 versus the VAD group,
§p < 0.05 versus the FeD group
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control rats. The association between vitamin A and
iron deficiency (VAFeD) leads to higher hepatic Rarα
mRNA levels compared with vitamin A deficiency
(VAD), whereas no difference was observed in Rarα
mRNA levels between the VAFeD and Fe groups. No
differences were observed in hepatic Rxrβ mRNA
levels among the groups (Fig. 3).
Discussion
To explore how vitamin A deficiency alters hepcidin
expression and consequently affects iron metabolism,
the present study evaluated the expression of genes
involved in the HJV-BMP6-SMAD signaling pathway in
male Wistar rats treated with diets deficient in vitamin
A (VAD) or in iron (FeD) or with diet deficient in both
vitamin A and iron (VAFeD). Understanding the mecha-
nisms that control hepcidin gene expression (Hamp) is
an important goal in the treatment of anemia from
chronic diseases.
The iron-deficient group (FeD) showed lower iron
concentrations in the liver, spleen, and intestine and
lower serum iron status compared to those of thecontrol group (Additional file 1: Figure S1 and Additional
file 2: Table S1). The tissue and systemic iron deficiency of
FeD rats may have led to the lower levels of hepatic Bmp6
mRNA and consequent strong down-regulation of Hamp
mRNA levels compared to those of the control group.
These results are consistent with a previous study (Pagani
et al. 2011) that found that iron deficiency inhibits hepcidin
due to the inhibition of the BMP-SMAD pathway as a con-
sequence of reductions in Bmp6 mRNA. Corradini et al.
(2011) suggested that liver iron concentration was the only
factor associated with hepatic Bmp6 mRNA levels and that
it is independent of transferrin saturation and serum
iron and hemoglobin concentration, which suggests
that hepatic Bmp6 induction is mediated by liver iron
concentration but not by transferrin saturation. Despite
hemojuvelin (HJV) acting as a BMP co-receptor in the
BMP-signaling pathway that modulates hepatic hepci-
din expression (Evstatiev and Gasche 2012), the iron
deficiency (FeD) did not alter hepatic Hfe2 mRNA
levels compared with those of the control. Krijt et al
(2012) observed no changes in membrane HJV protein
levels in rat livers subjected to iron overload and defi-
ciency. The authors suggested that substantial changes
Fig. 3 Relative transcript levels of retinoic acid receptor alpha (Rarα)
(a) and retinoid X receptor beta (Rxrβ) (b) in the livers normalized to
β-actin (Actb) values of rats treated with diets containing different
sources and amounts of vitamin A and iron for 59 days. Mean ± standard
deviation, *p< 0.05 versus the CT group, †p< 0.05 versus the VAD group,
§p< 0.05 versus the FeD group
Fig. 2 Relative transcript levels of divalent metal transporter 1 (Dmt1)
(a) and ferroportin 1 (Fpn1) (b) in the small intestines normalized to
β-actin (Actb) values of rats treated with diets containing different
sources and amounts of vitamin A and iron for 59 days. Mean ±
standard deviation, *p < 0.05 versus the CT group, †p < 0.05 versus
the VAD group, §p < 0.05 versus the FeD group
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brane hemojuvelin content and that this protein is not
a limiting step in the control of Hamp gene expression.
Although the vitamin A-deficient rats (VAD) have pre-
sented systemic iron deficiency (lower serum iron concen-
tration and transferrin saturation) like the iron-deficient
groups (FeD and VAFeD), they showed iron retention in
the spleen instead of a decrease as would be expected
(Additional file 1: Figure S1 and Additional file 2: Table
S1). Further, the vitamin A deficiency up-regulated hepatic
Bmp6 and Hfe mRNA levels in relation to those of the
control group and down-regulated hepatic Hamp mRNA
levels, despite similar iron levels in the liver, compared to
those of the control group (Fig. 1). This contradictory
response observed in the VAD group may be associated to
an inadequate erythropoiesis promoted by vitamin A defi-
ciency, due to the low availability of iron to expand the
erythroid tissue (Evans 2005; Frazer et al. 2012). The inad-
equate erythropoiesis was characterized in a set of other
experiments conducted in these rats (Cunha et al. 2014),
where the authors demonstrated that vitamin A deficiency
down-regulated renal Epo mRNA and up-regulated Hmox1in the spleen, suggesting an increased phagocytosis of
malformed or undifferentiated erythrocytes and conse-
quent iron accumulation in the spleen, in the heme form.
Frazer et al. (2012) observed that a chronic stimulated
erythropoiesis led to an increase in liver iron and Bmp6
mRNA levels and an unexpected decrease in hepatic
Hamp mRNA levels. A similar profile was also observed in
a model of hemolytic anemia, low serum iron status, and
high tissue iron concentration, where a reduction in hepci-
din expression occurs despite an increase in Bmp6 expres-
sion (Frazer et al. 2012).
Despite all-trans retinoic acid (atRA) being considered
the most active form of retinoids, rats treated with
12 mg/kg of atRA to replace retinyl ester presented de-
creased spleen, gut, and serum iron levels and low trans-
ferrin concentrations, in spite of their high liver iron
store in relation to that of the control group (Additional
file 1: Figure S1 and Additional file 2: Table S1). The low
intestinal iron level may lead to the down-regulation of
Fpn1 mRNA levels in the atRA, since during cellular
iron deprivation the iron regulatory protein (IRP1 or
IRP2)/iron responsive element (IRE) system (IRP/IRE)
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ation and preserve cellular iron (Jiang et al. 2012; Galy
et al. 2013; Sangokoya et al. 2013). Moreover, the atRA
diet did not restore the levels of hepatic Hamp mRNA
in the atRA group (Fig. 1) compared to those in the con-
trol group, and the expression of hepatic Bmp6 and Hfe2
genes that are involved in the activation of hepatic hep-
cidin expression through the BMP-SMAD-HJV pathway
was similar to that obtained for the control group. The
low systemic iron status of the atRA group in the
present study may be responsible for the lower Hamp
mRNA levels in the liver. Altogether, these contradictory
results suggest that the single atRA dose used (12 mg/kg
diet) must be suboptimal, either being too high or too
low for the physiological needs of rats. Deviations in
both directions are likely to induce an abnormal re-
sponse (Martini et al. 1995).
Different proteins have been identified as negative reg-
ulators of hepcidin transcription, including the small
mothers against decapentaplegic protein 7 (SMAD 7),
which mediate a negative feedback response through the
BMP pathway (Mleczko-Sanecka et al. 2010). SMAD 7
and Hamp are coregulated in the liver of iron-loaded
mice, which suggests that a negative feedback loop is
initiated by activating signals (Kautz et al. 2008). Con-
sistent with the coregulation that has been proposed in
the literature, the lower levels of hepcidin mRNA that
were found in the FeD group were accompanied by
down-regulation of hepatic Smad7 mRNA levels, which
corroborates the idea that systemic and tissue iron defi-
ciency lead to low hepcidin concentrations and conse-
quently decrease Smad7 expression, the inhibitor of the
BMP pathway. The down-regulation of hepatic Smad7
mRNA levels in the VAD group may reflect the inhib-
ition of hepcidin by the systemic iron deficiency, as the
levels of Smad7 and Hamp are coregulated in the liver.
The association of both deficiencies (VAFeD group) re-
duced the iron concentrations in the liver, intestine,
and spleen (Additional file 1: Figure S1), which may ex-
plain the down-regulation of Hamp, Hfe2, Bmp6, and
Smad7 hepatic mRNA levels compared to that of the
VAD group (Fig. 1). These results suggest that iron
plays a central role in the modulation of the expression
of these genes.
Contrary to the present study, in our previous study
(Arruda et al. 2009), an up-regulation of Hamp ex-
pression in VAD rats was observed. However, these
apparent contradictory results may be explained by
differences in rats’ treatment. In the previous study,
during the acclimatization period (8 days), the rats
were maintained in a commercial rodent diet (Labina
Purina/Brazil) with a concentration of vitamin A and
iron six- and fivefold higher than the AIN-93G stan-
dardized diet, respectively. Considering that vitamin Ais fat-soluble, these rats might have higher vitamin A
content in the liver at the beginning of the experi-
ment, which may have led to a late establishment of
vitamin A deficiency and consequent difference in
Hamp response, between the studies.
Besides the post-transcriptional regulation of intes-
tinal ferroportin by the iron regulatory protein/iron re-
sponsive element (IRE) system in response to cellular
iron content, duodenal iron absorption and exportation
is also dramatically altered in response to changes in
erythropoietic signal and hematological parameters. In
the present study, the decrease in intestinal ferroportin
mRNA levels in the vitamin A-deficient group may be
associated with the decrease in kidney erythropoietin
mRNA levels (Cunha et al. 2014) and decreased serum
iron status once iron absorption and exportation is al-
tered in response to changes in erythropoietic signal
and hematological parameters. Srai et al (2010) showed
that a nephrectomy rat model of chronic renal failure
had decreased iron transport across the duodenal epi-
thelium compared with sham-operated controls, and
the treatment of these rats with Epo significantly in-
creased iron absorption. Their findings suggest that
Epo acts directly on intestinal enterocytes to regulate
dietary absorption. Similar results were observed in
Caco-2 cells treated with Epo, where higher protein
and mRNA levels of intestinal DMT-1 and FPN led to
increased iron uptake and efflux compared to those of
the control cells.
Considering that a transgenic mouse, in which retin-
oid signaling is impaired specifically in hepatocytes,
showed increased expression of hemojuvelin and hepci-
din (Tsuchiya et al. 2009), we investigated if modulation
of Hamp mRNA levels by vitamin A involves retinoic
acid receptor (Rarα) or retinoid X receptor beta (Rxrβ).
Although the atRA diet promoted up-regulation and
the VAD diet promoted down-regulation of retinoic
acid receptor (Rarα) mRNA levels in the liver, in both
treatments, Hamp mRNA levels were reduced (Fig. 3).
These results suggest that vitamin A deficiency influ-
ences hepcidin expression in an indirect way that does
not involve the hepatic Rarα receptor.Conclusions
In conclusion, this study demonstrates that the HJV-
BMP6-SMAD signaling pathway that normally activates
the expression of hepcidin in iron deficiency is im-
paired by vitamin A deficiency despite increased ex-
pression of liver Bmp6 and Hfe2 mRNA levels and
decreased expression of Smad7 mRNA. The impair-
ment of HJV-BMP6-SMAD signaling pathway may be
associated to the systemic iron deficiency and spleen
iron retention promoted by vitamin A deficiency.
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Additional file 1: Figure S1. Iron concentration in the liver (A), small
intestine (B), and spleen (C) of rats treated with diets containing different
sources and amounts of vitamin A and iron for 59 days. Mean ± standard
deviation, * p < 0.05 versus the CT group, † p < 0.05 versus the VAD group,
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Additional file 2: Table S1. Hematological parameters of rats treated
with diets containing different sources and amounts of vitamin A and
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